Evidence map›Paper›PMID 39372807›Full record

ArticleDigital health

Automatic selection model to identify neurodegenerative diseases.

Eddy Sánchez-DelaCruz, Cecilia-Irene Loeza-Mejía, César Primero-Huerta, Mirta Fuentes-Ramos

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eddy Sánchez-DelaCruzArtificial Intelligence Laboratory, Tecnológico Nacional de México/Instituto Tecnológico Superior de Misantla, Veracruz, Mexico.ORCID https://orcid.org/0000-0002-2357-7799
Cecilia-Irene Loeza-MejíaArtificial Intelligence Laboratory, Tecnológico Nacional de México/Instituto Tecnológico Superior de Misantla, Veracruz, Mexico.ORCID https://orcid.org/0000-0002-4584-0076
César Primero-HuertaArtificial Intelligence Laboratory, Tecnológico Nacional de México/Instituto Tecnológico Superior de Misantla, Veracruz, Mexico.
Mirta Fuentes-RamosArtificial Intelligence Laboratory, Tecnológico Nacional de México/Instituto Tecnológico Superior de Misantla, Veracruz, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study evaluates machine learning algorithms' effectiveness in classifying Parkinson's disease and Huntington's disease based on biomarker data obtained non-invasively from patients and healthy controls. Methods: Datasets containing biomarker data ( Results: The study achieved a 0.893 precision rate for Parkinson's disease and Huntington's disease using the random subspace method. The findings underscore the potential of machine learning techniques in medical diagnosis, particularly in neurological disorders. Conclusion: The automatic selection model method demonstrated efficacy in classifying Parkinson's disease and Huntington's disease based on non-invasive biomarker data. This research contributes to advancing non-invasive diagnostic approaches in neurological disorders, highlighting the significance of machine learning in healthcare.

Indexed as

automated machine learningbiomarkersHuntington’s diseasemachine learningParkinson’s disease

Identifiers

PMID39372807
PMCPMC11456181

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.